deferoxamine has been researched along with 2,2'-(hydroxynitrosohydrazono)bis-ethanamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
BrĂ¼ne, B; Callapina, M; Deitmer, JW; Lohr, C; Metzen, E; Schnitzer, S; Zhou, J | 1 |
Bartosz, G; Lewinska, A | 1 |
2 other study(ies) available for deferoxamine and 2,2'-(hydroxynitrosohydrazono)bis-ethanamine
Article | Year |
---|---|
Nitric oxide reverses desferrioxamine- and hypoxia-evoked HIF-1alpha accumulation--implications for prolyl hydroxylase activity and iron.
Topics: Amino Acids, Dicarboxylic; Caspase 3; Caspases; Cell Hypoxia; Cell Line; Cysteine Proteinase Inhibitors; Deferoxamine; Enzyme Inhibitors; Ferric Compounds; Gene Expression; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Iron; Leupeptins; Nitric Oxide; Nitric Oxide Donors; Procollagen-Proline Dioxygenase; Proteasome Endopeptidase Complex; Proteasome Inhibitors; S-Nitrosoglutathione; Transcription Factors; Triazenes; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Von Hippel-Lindau Tumor Suppressor Protein | 2005 |
Yeast flavohemoglobin protects against nitrosative stress and controls ferric reductase activity.
Topics: Cell Division; Deferoxamine; Dioxygenases; Dose-Response Relationship, Drug; Ferricyanides; FMN Reductase; Gene Deletion; Hemeproteins; Hydrogen Peroxide; Mutation; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Oxidation-Reduction; Penicillamine; Peroxynitrous Acid; S-Nitrosoglutathione; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sodium Hypochlorite; Time Factors | 2006 |